Cite

HARVARD Citation

    Guo, X. et al. (n.d.). Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. International journal of cancer. 139 (8), pp. 1821-1829. [Online]. 
  
Back to record